Translational Research Fellowship: Awardees & Reports
2012-2013 Fellowships
Prognostic and predictive role of Ki67 determined on metastatic tissue of patients with advanced breast cancer
Fellow: Claudette Falato
Home Institute: National Cancer Institute, Naples, Italy
Host institute: Karolinska University Hospital, Stockholm, Sweden
Sponsor: Roche
Metabolomic and pharmacological patterns of resistance to the tyrosine kinase inhibitor sunitinib in patients with advanced renal-cell cancer
Fellow: Jennifer Gibbons Marsico
Home Institute: Instituto Nacional del Cancer (INCA), Montevideo, Uruguay
Host institute: Kantonsspital St Gallen, Switzerland
Sponsor: Roche
Feasibility evaluation of proliferation and nucleoside transport using FLT PET imaging in advanced pancreatic cancer patients
Fellow: Angela Lamarca
Home Institute: Hospital Universitario La Paz, Madrid, Spain
Host institute: The Christie NHS Foundation Trust, Manchester, UK
Sponsor: Amgen
Characterisation of individual foci of multicentric/multifocal breast cancer
Fellow: Elisabetta Pietri
Home institute: Istituto Tumori della Romagna I.R.S.T. , Meldola, Italy
Host institute: Institut Jules Bordet - Breast Cancer Translational Research Laboratory, Brussels, Belgium
Sponsor: Amgen
Identification of multiple synthetic lethal interactions with the BRAF oncogene in colorectal cancer
Fellow: Loredana Vecchione
Home institute: Katholieke Universities Leuven - Gasthuisberg University Hospital, Leuven, Belgium
Host institute: Department of Molecular Carcinogenesis B7 - NKI - Antoni van Leeuwenhoek Ziekenhuis - Prof Rene Bernards, Amsterdam, The Netherlands
Sponsor: Roche
2011-2012 Fellowships
Identification and validation of targeted Therapeutics in triple negative breast cancer (Translational Research within Neobig programme)
Fellow: Daniela Kolarevic
Home institute: Institute for Oncology and Radiology of Serbia, Belgrade, Serbia
Host institute: Breakthrough Breast Cancer Research Unit, Guy's and St. Thomas Hospital, London, UK
Sponsor: Roche
Investigation of DNA repair deficiencies in Non Small Cell Lung Cancer and therapeutic applications using synthetic lethality.
Fellow: Sophie Postel-Vinay
Home institute: Institut Gustave Roussy, Paris, France
Host institute: The Institute of Cancer Research, London, UK
Sponsor: Roche
2010-2011 Fellowships
Circulating tumour cells in metastatic breast cancer: it is time to detect and genotyping
Fellow: Leticia De Mattos-Arruda
Home institute: Santa Casa de Misericórdia de Belo Horizonte, Faculdade de Ciências Médicas de Minas Gerais, Belo Horizonte, MG, Brazil
Host institute: Vall d´Hebron University Hospital, Barcelona, Spain
Sponsor: Amgen
Genomic Profiling of Breast Cancer diagnosed during pregnancy
Fellow: Hatem Azim
Home institute: National Cancer Institute, Cairo Oncology Centre, Mohandeseen, Egypt
Host institute: Jules Bordet Institute, Brussels, Belgium
Sponsor: Roche
Molecular characterisation of the stromal microenvironment in pancreatic adenocarcinoma and its role in tumour progression and prognosis
Fellow: Konstantinos-Vellios Kamposioras
Home institute: University Hospital of Larissa, Greece
Host institute: St. James Institute of Oncology Level 4, Bexley Wing, St. James University Hospital, Leeds, UK
Sponsor: Roche
Molecular and genetic analysis of stromal fibroblasts in prostate cancer
Fellow: Michalis Karamouzis
Home institute: Medical School, University of Athens, Greece
Host institute: Department of Biological Chemistry, Medical School, University of Athens, Greece
Sponsor: Amgen
Identification of novel molecular targets and biological agents for the chemotherapy of malignant Pleural Mesothelioma
Fellow: Giulia Pasello
Home institute: Second Medical Oncology Unit, Instituto Oncologico Veneto, Padova Italy
Host institute: Department of Oncological and Surgical Sciences, Oncology Section, Istituto Oncologico Veneto, Padova, Italy
Sponsor: Roche
Exploring the tumour microenvironment with focus on Placental growth factor and colorectal cancer
Fellow: Karin Tamas
Home institute: Szent Laszlo Teaching Hospital, Budapest, Hungary
Host institute: University Medical Center Groningen, The Netherlands
Sponsor: Roche
Use of MEK inhibitors to overcome primary and acquired resistance to anti-EGFR therapies
Fellow: Teresa Troiani
Home institute: Oncologia Medica, Seconda Università Degli Studi di Napoli, Dipartimento di Internistica Clinica e Sperimentale "F. Magrassie E Lanzara", Naples, Italy
Host institute: Oncologia Medica, Seconda Università Degli Studi di Napoli, Dipartimento di Internistica Clinica e Sperimentale "F. Magrassie E Lanzara", Naples, Italy
Sponsor: Amgen